When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Aortic regurgitation

Evidence last reviewed: 28 Mar 2026
Topic last updated: 21 Apr 2026

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • diastolic murmur
Full details

Other diagnostic factors

  • dyspnoea
  • fatigue
  • weakness
  • orthopnoea
  • paroxysmal nocturnal dyspnoea
  • pallor
  • mottled extremities
  • rapid and faint peripheral pulse
  • jugular venous distension
  • basal lung crepitations
  • altered mental status
  • urine output <30 mL/hour
  • soft S1
  • soft or absent A2
  • collapsing (water hammer or Corrigan's) pulse
  • cyanosis
  • tachypnoea
  • displaced, hyperdynamic apical impulse
  • chest pain
  • pink frothy sputum
  • wheeze (cardiac asthma)
  • additional heart sounds
  • arrhythmias
  • ejection systolic flow murmur
  • Austin Flint murmur
  • systolic thrill
  • Hill's sign
  • bisferiens pulse
  • de Musset's sign
  • Muller's sign
  • Traube's sign
  • Quincke's sign
  • Duroziez's sign
  • Mayen's sign
  • Lighthouse sign
  • Becker's sign
  • Landolfi's sign
  • Rosenbach's sign
  • Gerhardt's sign
  • Lincoln's sign
  • Sherman's sign
  • palmar click
  • syncope
Full details

Risk factors

  • bicuspid aortic valve
  • rheumatic fever
  • endocarditis
  • Marfan's syndrome and related connective tissue disease
  • systemic hypertension
  • aortitis
  • older age
Full details

Diagnostic investigations

1st investigations to order

  • ECG
  • chest x-ray
  • echocardiogram
  • M-mode and 2-dimensional imaging
  • colour flow Doppler
  • pulsed wave Doppler
  • continuous wave Doppler
Full details

Investigations to consider

  • radionuclide angiography
  • MRI
  • exercise stress testing
  • cardiac catheterisation
Full details

Treatment algorithm

ACUTE

acute AR

ONGOING

chronic AR: mild to moderate

chronic AR: severe, asymptomatic

chronic AR: severe, symptomatic

Contributors

Authors

Poorna R. Karuparthi, MD, FACC

Associate Professor of Medicine

University of Missouri-Columbia

Chief of Cardiology

Harry S. Truman Veterans' Hospital

Columbia

MO

Declarações

PRK declares that he has no competing interests.

Agradecimentos

Dr Poorna R. Karuparthi would like to gratefully acknowledge Dr Sanjeev Wasson and Dr Nishant Kalra, previous contributors to this topic.

Declarações

SW and NK declare that they have no competing interests.

Revisores

Kul Aggarwal, MD, MRCP, FACC, FACP

Professor of Clinical Medicine

University of Missouri-Columbia

Chief

Cardiology Section

Harry S. Truman Veterans Hospital

Columbia

MO

Disclosures

KA declares that he has no competing interests.

Rajdeep Khattar, DM, FRCP, FACC, FESC

Consultant Cardiologist and Honorary Senior Clinical Lecturer

Manchester Heart Centre

Central Manchester and Manchester Children's NHS Foundation Trust

Manchester

UK

Disclosures

RK declares that he has no competing interests.

John Pepper, MChir FRCS

Consultant Cardiac Surgeon

Department of Surgery

Royal Brompton Hospital

London

UK

Disclosures

JP declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Writing Committee Members, Otto CM, Nishimura RA, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021 Feb 2;77(4):e25-197.Full text  Abstract

Praz F, Borger MA, Lanz J, et al. 2025 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2025 Nov 21;46(44):4635-736.Full text

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Aortic regurgitation images
  • Diagnósticos diferenciais

    • Mitral regurgitation (MR)
    • Mitral stenosis
    • Aortic stenosis
    More Diagnósticos diferenciais
  • Diretrizes

    • 2025 ESC/EACTS guidelines for the management of valvular heart disease
    • 2020 ESC guidelines for the management of adult congenital heart disease
    More Diretrizes
  • Folhetos informativos para os pacientes

    Heart failure

    Mais Folhetos informativos para os pacientes
  • Videos

    Aortic regurgitation (severe)

    Third heart sound gallop

    Mais vídeos
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal